Strategic partnerships There is a history of acquisition and collaboration with Bio-Rad and a dedicated global sales and service network. Use this to position RainDance as a scalable partner for academic and clinical labs seeking validated droplet-based PCR and targeted sequencing enrichment.

Liquid biopsy focus RainDance specializes in non-invasive liquid biopsy applications with RainDrop Digital PCR and ThunderStorm/ThunderBolts NGS enrichment. Target cancer research and infectious disease labs aiming for early, cost-effective detection and high-sensitivity assays.

Growth signals Recent product updates with RainDrop Plus Digital PCR System indicate an emphasis on faster droplet detection and higher throughput. Sales opportunities exist with labs needing accelerated workflows and automated analysis capabilities.

Scale-ready Small company footprint but strong enterprise-aligned tech stack and global distributors. Upsell opportunities may exist with larger genomics centers upgrading to integrated enrichment plus digital PCR platforms for comprehensive workflows.

Funding and valuation cues Historical funding and a sizable exit by Bio-Rad suggest credibility and potential for multi-site deployments. Leverage this to engage procurement teams in mid-to-large-sized research institutions seeking validated, time-saving genomic tools.